PUBLISHER: The Business Research Company | PRODUCT CODE: 1760466
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760466
Asbestosis treatment refers to the medical care provided to individuals affected by asbestosis, a chronic lung disease caused by prolonged exposure to asbestos fibers. The treatment aims to improve the patient's quality of life by alleviating respiratory difficulties, reducing inflammation, and slowing the progression of the disease.
The primary treatment types for asbestosis include medications such as salbutamol, guaifenesin, acetaminophen, and prednisone, among others. Salbutamol, a bronchodilator, is commonly used to relieve symptoms of asthma and chronic obstructive pulmonary disease (COPD). Treatment options encompass medication, surgery, rehabilitation, and palliative care. Administration methods vary, including oral, inhalation, intravenous, and other routes. These treatments are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The asbestosis treatment market research report is one of a series of new reports from The Business Research Company that provides asbestosis treatment market statistics, including asbestosis treatment industry global market size, regional shares, competitors with an asbestosis treatment market share, detailed asbestosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the asbestosis treatment industry. The asbestosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The asbestosis treatment market size has grown strongly in recent years. It will grow from $1.61 billion in 2024 to $1.75 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to growing industrialization, rising awareness of the risks associated with asbestos exposure, government health initiatives, increased healthcare spending, and extensive media coverage of asbestos-related diseases.
The asbestosis treatment market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to the increasing focus on rare disease research, a growing geriatric population, the expansion of telemedicine services, rising investments in pulmonary research, and the emergence of targeted biologics. Major trends in the forecast period include artificial intelligence-powered diagnostic tools, wearable respiratory monitoring devices, gene therapy innovations, nanotechnology-based drug delivery, the use of telemedicine for respiratory care, and the development of antifibrotic drugs.
The growing prevalence of asbestosis is expected to drive the expansion of the asbestosis treatment market in the coming years. Asbestosis is a chronic lung disease caused by prolonged exposure to asbestos fibers, leading to lung tissue damage and respiratory issues. The rising incidence of asbestosis is attributed to extended occupational exposure to asbestos, particularly among workers in industries such as construction, shipbuilding, and heavy manufacturing, where safety regulations may be insufficient. Asbestosis treatments help manage the disease by improving lung function and alleviating symptoms, thereby enhancing the quality of life for affected individuals. For example, in November 2024, the Health and Safety Executive, a UK-based government agency, reported 493 deaths from asbestosis in 2022, all among males. Consequently, the growing prevalence of asbestosis is driving the growth of the treatment market.
The increasing prevalence of respiratory diseases is expected to contribute to the growth of the asbestosis treatment market. Respiratory diseases encompass a wide range of conditions affecting the lungs and other parts of the respiratory system, including the nose, throat, and airways. The rising occurrence of these diseases is largely due to escalating air pollution, which exposes individuals to harmful pollutants that irritate the airways and worsen lung function. Asbestosis treatment aids in managing respiratory conditions by targeting lung inflammation and fibrosis, helping to slow disease progression and ease symptoms. This contributes to enhanced quality of life through medication, rehabilitation, and supportive care, improving chronic disease management. For instance, the Australian Bureau of Statistics reported 361 deaths from acute respiratory infections in 2023, a significant increase from 241 deaths in 2022. As a result, the increasing prevalence of respiratory diseases is a key factor driving the growth of the asbestosis treatment market.
In January 2025, ICV Partners, a US-based investment firm, announced its acquisition of Environmental Remedies LLC. This acquisition aims to accelerate the growth of ERI by expanding its geographic reach, improving operations, and pursuing strategic acquisitions, further solidifying its position as a leading provider of asbestos abatement and environmental remediation services in California. Environmental Remedies LLC specializes in asbestos abatement and environmental remediation, helping to prevent health risks such as asbestosis.
Major players in the asbestosis treatment market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck and Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Granules India Ltd., FibroGen Inc, Farmson Basic Drugs Pvt. Ltd., Atabay Pharmaceuticals and Fine Chemicals Inc., AMGIS Lifescience Ltd., Conscientia Industrial Co. Ltd., Sri Krishna Pharmaceuticals Ltd., Manus Aktteva Biopharma LLP, Thykn India International, Zhejiang Haizhou Pharmaceutical Co. Ltd., Inopha International Co. Limited, Synthokem Labs Pvt. Ltd.
North America was the largest region in the asbestosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in asbestosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the asbestosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The asbestosis treatment market consists of revenues earned by entities by providing services such as diagnostic evaluations, oxygen therapy, and long-term respiratory care aimed at alleviating symptoms and improving the quality of life for patients with asbestosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The asbestosis treatment market also includes sales of oxygen delivery systems, inhalers, nebulizers, and other respiratory support devices used to manage and treat asbestosis symptoms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Asbestosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on asbestosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for asbestosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The asbestosis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.